BLAKE MICHAEL BODENDORFER M.D.
Prescription History 1083000905
Orthopaedic Surgery - Sports Medicine in Council Bluffs, IA

NPI Status: Active since April 07, 2015

Contact Information

1 EDMUNDSON PL STE 500
COUNCIL BLUFFS, IA
ZIP 51503
Phone: (712) 323-5333

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for BLAKE MICHAEL BODENDORFER M.D., an active Sports Medicine specialist practicing in Council Bluffs, IA. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 368 documented patient claims. Among these therapy options, the most frequently utilized medication is Meloxicam, which accounts for 144 claims alone.


Celecoxib

Generic Formulation: CelecoxibSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 11
30-Day Fills 16.0
Days Supply 480
IA State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills52.3
Peer Average Days Supply1,521
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 65.6% less volume than the regional standard for practitioners inside IA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $180.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.43

State Avg Cost Per Claim

$51.48

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.

Therapeutic Applications

This medication is a nonsteroidal anti-inflammatory drug (NSAID), specifically a COX-2 inhibitor, which relieves pain and swelling (inflammation). It is used to treat arthritis, acute pain, and menstrual pain and discomfort. The pain and swelling relief provided by this medication helps you perform more of your normal daily activities. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. This drug works by blocking the enzyme in your body that makes prostaglandins. Decreasing prostaglandins helps to reduce pain and swelling.

Cephalexin

Generic Formulation: CephalexinSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 40
IA State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills33.1
Peer Average Days Supply396
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 63.3% less volume than the regional standard for practitioners inside IA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $160.78 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.62

State Avg Cost Per Claim

$7.80

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 94
30-Day Fills 94.0
Days Supply 707
IA State Average Benchmarks
Peer Average Claims62.0
Peer Average 30-Day Fills63.0
Peer Average Days Supply1,102
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 51.6% higher than the standard regional baseline profile for IA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,234.27 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.13

State Avg Cost Per Claim

$21.05

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Meloxicam

Generic Formulation: MeloxicamSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 144
30-Day Fills 210.0
Days Supply 6,205
IA State Average Benchmarks
Peer Average Claims50.0
Peer Average 30-Day Fills87.9
Peer Average Days Supply2,589
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 188.0% higher than the standard regional baseline profile for IA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $889.58 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.18

State Avg Cost Per Claim

$5.77

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.

Therapeutic Applications

Meloxicam is used to help relieve moderate to severe pain. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling or pain.

Methylprednisolone

Generic Formulation: MethylprednisoloneSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 18
30-Day Fills 18.0
Days Supply 105
IA State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills27.5
Peer Average Days Supply180
Conservative Utilization

This provider writes prescriptions for this formulation 33.3% less frequently than the standard regional baseline metric for practitioners inside IA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $150.08 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.34

State Avg Cost Per Claim

$10.58

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A PREDNISOLONE derivative with similar anti-inflammatory action.

Therapeutic Applications

Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders.

Ondansetron Hcl

Generic Formulation: Ondansetron HclSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 56
30-Day Fills 56.0
Days Supply 334
IA State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills22.0
Peer Average Days Supply147
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 154.5% higher than the standard regional baseline profile for IA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $443.53 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.92

State Avg Cost Per Claim

$10.14

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting.

Ondansetron Odt

Generic Formulation: OndansetronSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 23
30-Day Fills 23.0
Days Supply 107
IA State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills21.1
Peer Average Days Supply195
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $125.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.48

State Avg Cost Per Claim

$21.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Therapeutic Applications

This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting.

Sulfamethoxazole-Trimethoprim

Generic Formulation: Sulfamethoxazole/TrimethoprimSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 145
IA State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills27.5
Peer Average Days Supply409
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 54.2% less volume than the regional standard for practitioners inside IA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $101.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.27

State Avg Cost Per Claim

$6.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.

Therapeutic Applications

This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like BLAKE MICHAEL BODENDORFER M.D. provides transparency into local medical care patterns within Council Bluffs, IA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Sports Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.